OncoDaily: Richard Pazdur is the New Director of the FDA’s Drug Center: New Chapter of Legacy
In 2025, Dr. Pazdur received the American Association for Cancer Research (AACR) Enduring Impact Award for Transformative Service to Cancer Science and Medicine, a recognition of his profound influence on oncology research and policy. His honors also include the Reagan–Udall Foundation Leadership Award, the Harvey W. Wiley FDA Alumni Award, and distinctions from leading professional societies such as the American Society of Clinical Oncology (ASCO).